Pliant Therapeutics, Inc. - Common Stock (PLRX)

Pliant Therapeutics Inc is a biotechnology company focused on the development of innovative therapies for fibrotic diseases

The company is dedicated to discovering and advancing novel treatments that address the underlying mechanisms of tissue scarring and fibrosis across various organs. By leveraging its expertise in cellular and molecular biology, Pliant aims to transform the lives of patients suffering from debilitating conditions caused by excessive connective tissue growth, ultimately contributing to improved health outcomes and better quality of life.